Manufacturers Life Insurance Company, The Entrada Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 56,557 shares of TRDA stock, worth $609,118. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,557
Previous 56,855
0.52%
Holding current value
$609,118
Previous $909,000
7.48%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TRDA
# of Institutions
104Shares Held
28.9MCall Options Held
40.3KPut Options Held
4.1K-
Baker Bros. Advisors LP New York, NY4.87MShares$52.4 Million0.93% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$47.5 Million33.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$47.2 Million60.89% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.9MShares$31.3 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X02.08MShares$22.4 Million0.02% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $338M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...